Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion.

Add to Collection

2021 Dec Others AK Das, P Gandhi, B Saboo, S Reddy… - Journal of Family …, 2021 - ncbi.nlm.nih.gov 10

Full Author : ['Das, Ashok K', 'Gandhi, Pramod', 'Saboo, Banshi', 'Reddy, Sanjay', 'Chawla, Rajeev', 'Zargar, Abdul Hamid', 'Kovil, Rajiv', 'Chawla, Manoj', 'Sharma, S K', 'Gupta, Sunil', 'Makkar, B M', 'Mittal, Vinod', 'Goswami, Soumik', 'Arvind, S R', 'Jaggi, Shalini', 'Bajaj, Sarita', 'Das, Sambit']
Journal Title : Journal of family medicine and primary care
Chapter : Section4
Journal Year : 2021

The expanding burden of Type 2 Diabetes Mellitus (T2DM) in today's world, with respect to incidence, prevalence, and cost incurred, is an existential risk to society. Various guidelines recommend individualization of treatment. This expert opinion aims to..... Read More

Keywords : ['newly diagnose type diabetes mellitus', 'expert opinion', 'dipeptidyl inhibitor', 'treatment', 'optimize', 'metformin', 'combination']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884309/

Have a Question?

Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion.